FindTrial
Sign In

Use of a special technique of radiotherapy in nasophayngeal cancer,its advantage & side effects

A retrospective analysis of adult nasopharyngeal carcinoma treated with Intensity Modulated RadioTherapy (IMRT) at Tata Memorial Hospital (TMH).

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/11/010345
Enrollment
150
Registered
2017-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed case of Nasopharyngeal Cancer

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: ) Histopathologically confirmed carcinoma Nasopharynx 2) Age >18 years 3) Completed all planned treatment at TMH and received IMRT for treatment Of their locoregional disease. 4) On regular follow-up

Exclusion criteria

Exclusion criteria: 1) Patients who have received treatment outside or who have not completed planned treatment 2) Not on regular follow-up

Design outcomes

Primary

MeasureTime frame
To analyze the outcomes (loco regional control, disease free survival, overall survival) of adult NPC patients treated with IMRTTimepoint: after Completion of radiotherapy—

Secondary

MeasureTime frame
To report on toxicity of these patients wherever available (Xerostomia, hypothyroidism, Trismus, auditory abnormalities, visual abnormalities, etc)Timepoint: After completion of planned treatment—

Countries

India

Contacts

Public ContactDr Sachin Hirve

Tata Memorial Hospital

sarbanilaskar@yahoo.co.in02224177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026